Canaccord Genuity Keeps 'Speculative Buy' Rating on AEterna Zentaris (AEZS) After AEZS-108 and Perifosine Data Presented at ASCO
Tweet Send to a Friend
Canaccord Genuity maintains a 'Speculative Buy' rating on AEterna Zentaris (Nasdaq: AEZS), price target $2.60.
Canaccord analyst says, "Æterna Zentaris ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "Æterna Zentaris ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
